The Pharma & Biopharma Outsourcing Association (PBOA), a new non-profit trade association devoted to advancing the interests of CMOs, CDMOs and other service providers, has elected Peter Bigelow to serve as chairman of the Board of Trustees.
 
Mr. Bigelow will work with the board and with PBOA president Gil Roth to develop PBOA’s agenda, represent the association in its regulatory, legislative and business mission, and serve as liaison between the board and the member companies. He will serve an initial term of two years, effective immediately.
 
Mr. Bigelow commented, “The strategic importance of outsourcing partnerships has grown immensely in the pharmaceutical development and manufacturing industry. The PBOA represents a great opportunity for the industry to make progress on key issues. I am very pleased to be a part of this new and exciting organization.”
 
Mr. Roth added, “I worked with Peter for several years during my time as editor of Contract Pharma magazine. Based on our interactions and his experience working for both CDMOs and pharma/biopharma companies, I believe he’ll do a fantastic job as the Chairman of the PBOA.”
 
Peter is the president of xCell Strategic Consulting, a consulting firm to the pharmaceutical industry. He recently served as interim president of the Qualitest Pharma division of Endo Health Solutions, Inc. Prior to founding xCell, he served as the president of North America Commercial Operations at Patheon, and also held the role of CEO.